Your browser doesn't support javascript.
loading
Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.
Heise, Mark; Dillard, Jacob; Taft-Benz, Sharon; Knight, Audrey; Anderson, Elizabeth; Pressey, Katia; Parotti, Breantié; Martinez, Sabian; Diaz, Jennifer; Sarkar, Sanjay; Madden, Emily; De la Cruz, Gabriela; Adams, Lily; Dinnon, Kenneth; Leist, Sarah; Martinez, David; Schaefer, Alexandra; Powers, John; Yount, Boyd; Castillo, Izabella; Morales, Noah; Burdick, Jane; Evangelista, Mia Katrina; Ralph, Lauren; Pankow, Nicholas; Linnertz, Colton; Lakshmanane, Prem; Montgomery, Stephanie; Ferris, Martin; Baric, Ralph; Baxter, Victoria.
Afiliación
  • Heise M; University of North Carolina at Chapel Hill.
  • Dillard J; University of North Carolina at Chapel Hill.
  • Taft-Benz S; University of North Carolina.
  • Knight A; Dallas Tissue Research.
  • Anderson E; University of North Carolina at Chapel HIll.
  • Pressey K; University of North Carolina at Chapel Hill.
  • Parotti B; University of North Carolina at Chapel Hill.
  • Martinez S; University of North Carolina at Chapel Hill.
  • Diaz J; University of North Carolina at Chapel Hill.
  • Sarkar S; Southern Research.
  • Madden E; EpiCypher.
  • De la Cruz G; University of North Carolina at Chapel Hill.
  • Adams L; Gryphon Scientific LLC.
  • Dinnon K; The Rockefeller University.
  • Leist S; University of North Carolina at Chapel Hill.
  • Martinez D; Yale University.
  • Schaefer A; University of North Carolina at Chapel Hill.
  • Powers J; University of North Carolina at Chapel Hill.
  • Yount B; Department of Epidemiology, Gillings School of Public Health, University of North Carolina at Chapel Hill.
  • Castillo I; University of North Carolina at Chapel Hill.
  • Morales N; University of North Carolina at Chapel Hill.
  • Burdick J; University of North Carolina at Chapel Hill.
  • Evangelista MK; University of North Carolina at Chapel Hill.
  • Ralph L; University of North Carolina at Chapel Hill.
  • Pankow N; University of North Carolina at Chapel Hill.
  • Linnertz C; University of North Carolina at Chapel Hill.
  • Lakshmanane P; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC.
  • Montgomery S; University of North Carolina at Chapel Hill.
  • Ferris M; University of North Carolina.
  • Baric R; University of North Carolina at Chapel Hill.
  • Baxter V; Texas Biomedical Research Institute, San Antonio, Texas, USA.
Res Sq ; 2023 Oct 27.
Article en En | MEDLINE | ID: mdl-37961507
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos